Rebbeca Med

Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment, and electronic equipment companies.

The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.

Rebbeca Med headquartered in Asia, operates in the Biotechnology, Medical Device sector. The company focuses on Biotechnology and has secured $277.0M in funding across 24 round(s). With a team of 11-50 employees, Rebbeca Med is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Rebbeca Med, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.